JP2012516852A - 認知機能改善および心拍数低下のための方法 - Google Patents

認知機能改善および心拍数低下のための方法 Download PDF

Info

Publication number
JP2012516852A
JP2012516852A JP2011548414A JP2011548414A JP2012516852A JP 2012516852 A JP2012516852 A JP 2012516852A JP 2011548414 A JP2011548414 A JP 2011548414A JP 2011548414 A JP2011548414 A JP 2011548414A JP 2012516852 A JP2012516852 A JP 2012516852A
Authority
JP
Japan
Prior art keywords
dha
acid
less
unit dose
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011548414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012516852A5 (cg-RX-API-DMAC7.html
Inventor
カリン ユルコ−マウロ
Original Assignee
マーテック バイオサイエンシーズ コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マーテック バイオサイエンシーズ コーポレーション filed Critical マーテック バイオサイエンシーズ コーポレーション
Publication of JP2012516852A publication Critical patent/JP2012516852A/ja
Publication of JP2012516852A5 publication Critical patent/JP2012516852A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2011548414A 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法 Withdrawn JP2012516852A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14931009P 2009-02-02 2009-02-02
US61/149,310 2009-02-02
US18354809P 2009-06-02 2009-06-02
US61/183,548 2009-06-02
PCT/US2010/022952 WO2010088700A1 (en) 2009-02-02 2010-02-02 Methods for improving cognitive function and decreasing heart rate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015057637A Division JP2015143248A (ja) 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法

Publications (2)

Publication Number Publication Date
JP2012516852A true JP2012516852A (ja) 2012-07-26
JP2012516852A5 JP2012516852A5 (cg-RX-API-DMAC7.html) 2013-03-21

Family

ID=42041547

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011548414A Withdrawn JP2012516852A (ja) 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法
JP2015057637A Pending JP2015143248A (ja) 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法
JP2018073345A Pending JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja) 2009-02-02 2019-12-27 認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja) 2009-02-02 2022-02-17 認知機能改善および心拍数低下のための方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2015057637A Pending JP2015143248A (ja) 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法
JP2018073345A Pending JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja) 2009-02-02 2019-12-27 認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja) 2009-02-02 2022-02-17 認知機能改善および心拍数低下のための方法

Country Status (8)

Country Link
US (2) US20100203123A1 (cg-RX-API-DMAC7.html)
EP (2) EP2939671A1 (cg-RX-API-DMAC7.html)
JP (5) JP2012516852A (cg-RX-API-DMAC7.html)
CN (3) CN104042600A (cg-RX-API-DMAC7.html)
AU (2) AU2016201382A1 (cg-RX-API-DMAC7.html)
CA (1) CA2751275A1 (cg-RX-API-DMAC7.html)
HK (1) HK1202243A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010088700A1 (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016518339A (ja) * 2013-03-15 2016-06-23 ジェンスペラ，インコーポレイテッド 癌組成物を作製する方法
JP2024180435A (ja) * 2020-07-02 2024-12-26 クリック セラピューティクス インコーポレイテッド デジタル治療プラセボおよびシャムの生成および施用のためのシステム、方法およびデバイス
WO2025100476A1 (ja) * 2023-11-10 2025-05-15 国立大学法人京都大学 生理機能改善用の組成物
JP2025079778A (ja) * 2023-11-10 2025-05-22 ダイドーグループホールディングス株式会社 生理機能改善用の組成物

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
CN103732223A (zh) * 2011-05-19 2014-04-16 加利福尼亚大学董事会 用于认知能力下降的医疗食品
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20130084272A1 (en) * 2011-09-29 2013-04-04 Philippe Perrin Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
CN115109804A (zh) 2013-12-20 2022-09-27 玛拉可再生能源公司 从微生物中回收油的方法
TR201503136A2 (tr) * 2015-03-16 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları.
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
CN110168071A (zh) 2016-12-22 2019-08-23 玛拉可再生能源公司 用于使用真核微生物产生富含dha、棕榈酸和蛋白质的生物质的方法
JP7101087B2 (ja) * 2018-09-05 2022-07-14 株式会社 伊藤園 軽度認知障害に対する緑茶成分の有効性評価方法
FR3092968B1 (fr) * 2019-02-22 2021-05-21 Microphyt Complement alimentaire
CN114555074A (zh) * 2019-08-08 2022-05-27 斯威本科技大学 长链多不饱和脂肪酸的用途
US12359230B2 (en) 2020-04-03 2025-07-15 MARA Renewables Corporation Microbial oils with high levels of omega-3 fatty acids
DE102020115238A1 (de) * 2020-06-09 2021-12-09 Pm-International Ag Nahrungsergänzungsmittel und Nahrungsmittel
JP2024504116A (ja) * 2021-01-15 2024-01-30 ケンブリッジ コグニション リミテッド 周術期神経認知障害及び／又はウイルス感染後認知障害の個人を特定する方法及びシステム
EP4637824A1 (en) * 2023-01-18 2025-10-29 Bioventures, Llc Method of preventing and treating alzheimer's disease and related dementias with drugs inhibiting the interaction between 14-3-3g protein and hexokinase-1 protein

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
JP2008528475A (ja) * 2005-01-24 2008-07-31 プロノヴァ バイオファーマ ノルゲ アクティーゼルスカブ アミロイドーシス関連疾患の治療のための医療品又は食料品の製造における、ｄｈａを含有する脂肪酸組成物の使用
JP2009502745A (ja) * 2005-07-08 2009-01-29 マーテック バイオサイエンシーズ コーポレーション 認知症および前認知症に関連した状態を治療するための多価不飽和脂肪酸

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
AU693450B2 (en) * 1993-06-09 1998-07-02 Martek Biosciences Corporation Methods and pharmaceutical compositions useful for treating neurological disorders
CA2197187C (en) 1994-08-16 2007-03-27 Bernd Best Process for extracting native products which are not water-soluble from native substance mixtures by means of centrifugal force
DE69637953D1 (de) * 1995-04-17 2009-07-30 Nat Inst Of Advanced Ind Scien Hoch ungesättigte fettsäurenproduzierende mikroorganismen und verfahren zur herstellung von hoch ungesättigten fettsäuren durch verwendung dieser mikroorganismen
JP3985035B2 (ja) * 1995-09-14 2007-10-03 独立行政法人産業技術総合研究所 （ｎ−６）系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途
ATE273373T1 (de) 1999-02-26 2004-08-15 Martek Biosciences Corp Verfahren zum abtrennen von einem docosahexaensäure enthaltenden triglyerid aus einem triglyceridgemisch
WO2001051598A1 (en) 2000-01-11 2001-07-19 Monsanto Technology Llc Process for making an enriched mixture of polyunsaturated fatty acid esters
ATE485385T1 (de) 2000-01-19 2010-11-15 Martek Biosciences Corp Lösungsmittelfreies extraktionsverfahren
ATE447332T1 (de) 2000-04-12 2009-11-15 Gea Westfalia Separator Gmbh Verfahren zur fraktionierung von öl- und polar lipid-enthaltenden rohstoffen unter verwendung von alkohol und zentrifugation
JP2004536059A (ja) 2001-05-14 2004-12-02 マーテック バイオサイエンシズ ボールダー コーポレーション 微生物、遺伝的に改変された植物種子および海洋生物由来のω−３および／またはω−６高度不飽和脂肪酸を含有する極性脂質の豊富な画分の生成および使用
WO2002092073A1 (en) 2001-05-14 2002-11-21 Martek Biosciences Corporation Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
AU2002320251A1 (en) * 2001-07-05 2003-01-21 Vital Basics, Inc. Compositions for improving mental performance
EP2266525B1 (en) 2002-05-03 2012-07-11 Martek Biosciences Corporation High quality lipids and methods for producing by enzymatic liberation from biomass
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
HUE031206T2 (en) * 2005-05-23 2017-06-28 Massachusetts Inst Technology Formulations and methods of application containing PUFA
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
US20090023808A1 (en) 2007-06-29 2009-01-22 Martek Biosciences Corporation Production and Purification of Esters of Polyunsaturated Fatty Acids
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528475A (ja) * 2005-01-24 2008-07-31 プロノヴァ バイオファーマ ノルゲ アクティーゼルスカブ アミロイドーシス関連疾患の治療のための医療品又は食料品の製造における、ｄｈａを含有する脂肪酸組成物の使用
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
JP2009502745A (ja) * 2005-07-08 2009-01-29 マーテック バイオサイエンシーズ コーポレーション 認知症および前認知症に関連した状態を治療するための多価不飽和脂肪酸

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6014011387; Ｃｌｉｎ　Ｅｘｐ　Ｐｈａｒｍａｃｏｌ　Ｐｈｙｓｉｏｌ ｖｏｌ．３３，　ｎｏ．９, 2006, ｐ．８４２-６ *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016518339A (ja) * 2013-03-15 2016-06-23 ジェンスペラ，インコーポレイテッド 癌組成物を作製する方法
JP2024180435A (ja) * 2020-07-02 2024-12-26 クリック セラピューティクス インコーポレイテッド デジタル治療プラセボおよびシャムの生成および施用のためのシステム、方法およびデバイス
WO2025100476A1 (ja) * 2023-11-10 2025-05-15 国立大学法人京都大学 生理機能改善用の組成物
JP2025079778A (ja) * 2023-11-10 2025-05-22 ダイドーグループホールディングス株式会社 生理機能改善用の組成物

Also Published As

Publication number Publication date
JP2022059063A (ja) 2022-04-12
EP2391361A1 (en) 2011-12-07
WO2010088700A1 (en) 2010-08-05
EP2939671A1 (en) 2015-11-04
JP2015143248A (ja) 2015-08-06
US20100203123A1 (en) 2010-08-12
CN102365087A (zh) 2012-02-29
US20130172412A1 (en) 2013-07-04
AU2010207929A1 (en) 2011-09-22
HK1202243A1 (en) 2015-09-25
CA2751275A1 (en) 2010-08-05
AU2016201382A1 (en) 2016-03-24
AU2017245327A1 (en) 2017-11-02
CN104042600A (zh) 2014-09-17
JP2020050675A (ja) 2020-04-02
JP2018104477A (ja) 2018-07-05
CN108324706A (zh) 2018-07-27

Similar Documents

Publication Publication Date Title
JP2022059063A (ja) 認知機能改善および心拍数低下のための方法
JP6419927B2 (ja) 対象の高感度（ｈｓ−ｃｒｐ）のレベルを低下させる組成物および方法
US11413263B2 (en) Reducing the risk of pathological effects of traumatic brain injury
ES2661217T3 (es) Composiciones y métodos para reducir los triglicéridos sin aumentar los niveles de LDL-C en un sujeto en terapia simultánea con estatinas
US20100130608A1 (en) Compositions and methods for reducing triglyceride levels
WO2011097273A1 (en) Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl lcystenine
EP2646013A2 (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US20110086914A1 (en) Methods for Treating Traumatic Brain Injury
US20110177061A1 (en) Methods of treating and preventing neurological disorders using docosahexaenoic acid
AU2010207929B2 (en) Methods for improving cognitive function and decreasing heart rate
WO2011041710A2 (en) Docosahexaenoic acid gel caps
HK1172241A (en) Reducing the risk of pathological effects of traumatic brain injury
HK1172241B (en) Reducing the risk of pathological effects of traumatic brain injury

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20121126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130131

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130131

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140317

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140613

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140620

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150320

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150430

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150512

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150710

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20151008